Month: September 2020

CORRECTING and REPLACING: CME Group to Launch First-Ever Water Futures Based on Nasdaq Veles California Water Index

Written by Customer Service on September 17, 2020. Posted in Public Companies.

CHICAGO and NEW YORK, Sept. 17, 2020 (GLOBE NEWSWIRE) — In a release issued under the same headline on Thursday, September 17th by Nasdaq, Inc., please note that a link in the contact information was leading to an inactive web page. The link has been updated and the corrected release follows:CME Group, the world’s leading and most diverse derivatives marketplace, and Nasdaq, a global technology company serving the capital markets and other industries, today announced plans for a new futures contract on the Nasdaq Veles California Water Index (NQH2O). CME Group will launch its new Nasdaq Veles California Water Index futures contract in late Q4, pending regulatory review.Nasdaq Veles California Water Index futures will be an innovative, first-of-its-kind tool to provide agricultural, commercial, and municipal water users with...

WSFS Bank and WSFS Community Foundation Pledge $35,500 to Provide Hundreds of Technology Devices to Area Students for Online Learning

Written by Customer Service on September 17, 2020. Posted in Public Companies.

WILMINGTON, Del., Sept. 17, 2020 (GLOBE NEWSWIRE) — Today, WSFS Bank, the primary subsidiary of WSFS Financial Corporation (Nasdaq: WSFS), announced a $35,500 pledge from the Bank and the WSFS Community Foundation to provide laptops, tablets and internet devices for students from low-to-moderate income families throughout the Bank’s footprint.As the pandemic has impacted school plans and curriculums, and with many districts turning to virtual or hybrid learning methods to start the school year, the need for technology devices for students has increased. The grants will be awarded to the following organizations and schools:United Way of Delaware for students in New Castle and Sussex Counties (Delaware)Independence Mission School (Philadelphia, Pa.)Widener Partnership Charter School (Chester, Pa.)KIPP School (Camden, NJ).“During this...

Efecte Plc – Managers’ transactions – Hovi

Written by Customer Service on September 17, 2020. Posted in Public Companies.

Efecte Plc – Managers’ transactions – Hovi____________________________________________ Person subject to the notification requirementName: Hovi, NiinaPosition: Other senior managerIssuer: Efecte PlcLEI: 7437005U8P0KDN6RKW34 Notification type: INITIAL NOTIFICATIONReference number: 7437005U8P0KDN6RKW34_20200917111116_28____________________________________________ Transaction date: 2020-09-16Venue not applicableInstrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENTInstrument name: Efecte Oyj 2018C-optionNature of the transaction: ACCEPTANCE OF A STOCK OPTION(X) Linked to stock option programme Transaction details(1): Volume: 7000 Unit price: 0.00 EUR Aggregated transactions(1): Volume: 7000 Volume weighted average price: 0.00 EUR Further inquiries:Taru MäkinenCFOEfecte Plctaru.makinen@efecte.com+358...

Efecte Oyj – Johdon liiketoimet – Hovi

Written by Customer Service on September 17, 2020. Posted in Public Companies.

Efecte Oyj – Johdon liiketoimet – Hovi____________________________________________ IlmoitusvelvollinenNimi: Hovi, NiinaAsema: Muu ylin johtoLiikkeeseenlaskija: Efecte OyjLEI: 7437005U8P0KDN6RKW34 Ilmoituksen luonne: ENSIMMÄINEN ILMOITUSViitenumero: 7437005U8P0KDN6RKW34_20200917111116_28____________________________________________ Liiketoimen päivämäärä: 2020-09-16Kauppapaikka ei sovelluInstrumentti tyyppi: RAHOITUSINSTRUMENTTI, JOKA LIITTYY OSAKKEESEEN TAI VIERAAN PÄÄOMAN EHTOISEEN INSTRUMENTTIINInstrumentin nimi: Efecte Oyj 2018C-optioLiiketoimen luonne: OSAKEOPTION HYVÄKSYMINEN(X) Liiketoimi liittyy osakeoptio-ohjelman toteuttamiseen Liiketoimien yksityiskohtaiset tiedot(1): Volyymi: 7000 Yksikköhinta: 0.00 EUR Liiketoimien yhdistetyt tiedot(1): Volyymi: 7000 Keskihinta: 0.00 EUR Lisätietoja:Taru MäkinenTalousjohtajaEfecte...

Address change of AS Baltika

Written by Customer Service on September 17, 2020. Posted in Public Companies.

AS Baltika announces that as of 01 October 2020 the company’s new legal address and actual location is Valukoja 10, 11415 Tallinn, Estonia. AS Baltika telephone is +372 6302700. Other contact information of AS Baltika will remain the same. AS Baltika subsidiary Baltman OÜ new legal and actual location will also be from 01 October 2020 Valukoja 10, 11415 Tallinn, Estonia. Flavio PeriniMember of Management Board, CEOflavio.perini@baltikagroup.com

AS Baltika aadressi muudatus

Written by Customer Service on September 17, 2020. Posted in Public Companies.

AS Baltika annab teada, et alates 01.10.2020 on ettevõtte uus registrijärgne aadress ning tegelik asukoht Valukoja 10, 11415 Tallinn, Eesti Vabariik. AS Baltika kontakttelefon on +372 6302700. AS Baltika muud kontaktandmed jäävad samaks. AS Baltika tütarettevõtte Baltman OÜ uus registrijärgne aadress ning tegelik asukoht on alates 01.10.2020 samuti Valukoja 10, 11415 Tallinn, Eesti Vabariik.Flavio PeriniJuhatuse liige, tegevjuhtflavio.perini@baltikagroup.com

3CL Protease Inhibitor NLC-001 Added to COVID-19-focused Joint Venture Between Todos Medical and NLC Pharma

Written by Customer Service on September 17, 2020. Posted in Public Companies.

NLC-001 is a proprietary blend of plant extracts administered orally as dietary supplement US FDA granted Certificate of Free Sale for NLC-001 on August 28, 2020 JV evaluating potential of NLC-001 to treat COVID-19 in clinical studies in Israel Todos evaluating commercialization options for NLC-001 WorldwideNEW YORK, REHOVOT, Israel and SINGAPORE, Sept. 17, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Todos Medical Ltd. (OTCQB: TOMDF), an in vitro diagnostics company focused on developing and distributing comprehensive solutions for COVID-19, and developing blood tests for the early detection of cancer and Alzheimer’s disease, today announced that NLC Pharma has added the dietary supplement NLC-001 to its joint venture with Todos Medical. NLC-001 is an orally administered proprietary blend of plant extracts that includes a...

Invesco Ltd.: Form 8.3 – G4S PLC

Written by Customer Service on September 17, 2020. Posted in Mergers And Acquisitions.

FORM 8.3PUBLIC DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)1. KEY INFORMATION2. POSITIONS OF THE PERSON MAKING THE DISCLOSUREIf there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)All interests and all short positions should be disclosed.Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8...

Atossa Therapeutics Receives Second Positive Interim Safety Assessment in Clinical Study of AT-301 Nasal Spray Being Developed for the Coronavirus Causing COVID

Written by Customer Service on September 17, 2020. Posted in Public Companies.

SEATTLE, Sept. 17, 2020 (GLOBE NEWSWIRE) — Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of significant unmet medical need with a current focus on breast cancer and COVID-19, today announced a positive interim safety assessment from the second cohort of healthy participants in the Phase 1 clinical study using Atossa’s proprietary drug candidate AT-301 administered by nasal spray. This second group of eight participants received a single escalated dose of either AT-301A (placebo) or AT-301B (active drug). The blinded, positive assessment by the safety committee allows the study to now enroll the next cohort, which will be the third of a total of four cohorts and the first of two multi-dose, placebo controlled cohorts.“This second...

Huntington Ingalls Industries Awards 193 Scholarships for the 2020-2021 School Year Through Annual Scholarship Fund

Written by Customer Service on September 17, 2020. Posted in Public Companies.

NEWPORT NEWS, Va., Sept. 17, 2020 (GLOBE NEWSWIRE) — Huntington Ingalls Industries (NYSE: HII) announced today that the HII Scholarship Fund, now in its fifth year, has awarded 100 new scholarships for the 2020-2021 school year. Additionally, the fund renewed 93 previously active scholarships. To date, 767 scholarships have been awarded or renewed for a total of more than $2 million.The HII Scholarship Fund was formed to provide financial assistance to dependent children of HII employees who are pursuing a post-secondary college or technical/vocation degree and to dependent children who are enrolled in quality pre-kindergarten school readiness programs. For the fifth year in a row, HII President and CEO Mike Petters declined all but $1 of his annual salary to fund the program that has helped provide educational opportunities to...

Month: September 2020

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals